StockData
Exagen Inc. logo

Exagen Inc. (XGN) stock

XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.90+0.14 (+3.72%)

Close on Nov 18, 2026Market cap $94.48MP/E –Yield –

Exagen operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Exagen's operating income for the twelve months ending Jun 30, 2026 was -$13.21M. For fiscal 2025 it was -$14.07M. The highest annual figure on record is -$4.88M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.07M–
FY2024Dec 31, 2024-$13.64M–
FY2023Dec 31, 2023-$22.84M–
FY2022Dec 31, 2022-$46.05M–
FY2021Dec 31, 2021-$24.07M–
FY2020Dec 31, 2020-$15.19M–
FY2019Dec 31, 2019-$9.30M–
FY2018Dec 31, 2018-$4.88M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.72M–
Q1 FY2026Mar 31, 2026-$3.41M–
Q4 FY2025Dec 31, 2025-$4.98M–
Q3 FY2025Sep 30, 2025-$3.10M–
Q2 FY2025Jun 30, 2025-$2.63M–
Q1 FY2025Mar 31, 2025-$3.37M–
Q4 FY2024Dec 31, 2024-$3.38M–
Q3 FY2024Sep 30, 2024-$4.66M–
Q2 FY2024Jun 30, 2024-$2.59M–
Q1 FY2024Mar 31, 2024-$3.00M–
Q4 FY2023Dec 31, 2023-$5.15M–
Q3 FY2023Sep 30, 2023-$5.07M–
Q2 FY2023Jun 30, 2023-$4.92M–
Q1 FY2023Mar 31, 2023-$7.71M–
Q4 FY2022Dec 31, 2022-$14.49M–
Q3 FY2022Sep 30, 2022-$7.82M–
Q2 FY2022Jun 30, 2022-$14.06M–
Q1 FY2022Mar 31, 2022-$9.68M–
Q4 FY2021Dec 31, 2021-$6.25M–
Q3 FY2021Sep 30, 2021-$6.50M–
Q2 FY2021Jun 30, 2021-$5.74M–
Q1 FY2021Mar 31, 2021-$5.57M–
Q4 FY2020Dec 31, 2020-$2.76M–
Q3 FY2020Sep 30, 2020-$3.79M–
Q2 FY2020Jun 30, 2020-$3.42M–
Q1 FY2020Mar 31, 2020-$5.22M–
Q4 FY2019Dec 31, 2019-$2.86M–
Q3 FY2019Sep 30, 2019-$2.16M–
Q2 FY2019Jun 30, 2019-$2.41M–
Q1 FY2019Mar 31, 2019-$1.87M–
Q4 FY2018Dec 31, 2018-$151.00K–
Q3 FY2018Sep 30, 2018-$1.13M–

More Exagen figures

See a number that looks wrong?